Cartilage Degeneration Market
Cartilage Degeneration Market By Procedure (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfractures, Meniscus Transplants, Cell-based Cartilage Resurfacing & Other), By Application (Knees, Hips), By Treatment Delivery Channels, By Region- Global Market Insights 2027
Analysis of Cartilage Degeneration Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cartilage Degeneration Market Outlook (2022-2027)
The global cartilage degeneration market is valued at US$ 12.1 billion in 2022 and is estimated to generate US$ 16 billion in revenue by the end of 2027, and expanding at a CAGR of 5.7% over the next five years.
An increasing number of joint replacement surgeries across the world is expected to drive demand for joint replacements at a CAGR of 6%, which is the highest among all procedures.
Report Attributes |
Details |
|---|---|
|
Cartilage Degeneration Market Size (2022) |
US$ 12.1 Billion |
|
Projected Market Value (2027F) |
US$ 16 Billion |
|
Global Market Growth Rate (2022-2027) |
5.7% CAGR |
|
United States Market Value (2022) |
US$ 3.4 Billion |
|
Canada Market Growth Rate (2022-2027) |
4.5% CAGR |
|
Joint Replacements Segment Market Value (2027F) |
US$ 5.7 Billion |
|
Japan Market Growth Rate (2022-2027) |
4.8% CAGR |
|
China Market Value (2027F) |
US$ 2.8 Billion |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Revenue Analysis of Cartilage Degeneration Treatment (2017-2021) Vs. Market Growth Estimations (2022-2027)
Cartilage degeneration leads to many complications and results in bone diseases such as osteoarthritis and the world has witnessed a notable increase in the incidence of such ailments. This trend is expected to be rife across the forecast period as well and is anticipated to primarily drive cartilage degeneration market growth through 2027.
Increasing incidence of accidents and trauma are also anticipated to drive the demand for cartilage repair over the years to come. The increasing geriatric population, rising prevalence of obesity, growing number of sports injuries, and technological advancements in the global cartilage repair market are other factors that influence cartilage degeneration market potential.
However, the high costs of cartilage repair therapies and the lack of favorable reimbursement scenarios in most countries are anticipated to have a restraining effect on the overall market growth going forward.
From 2022 to 2027, the global cartilage degeneration market is slated to exhibit expansion at a moderate CAGR of 5.7%.
What Aspects Will Determine Cartilage Degeneration Market Future?
“Growing Senescent Population & Increase in Sports Injuries Driving Market Progress”
The aging population has been increasing in most parts of the world and this sect of people is more prone to bone diseases and disorders as cartilages degrade over time with age. Countries such as China and the United States are anticipated to witness a notable rise in the geriatric population and emerge as lucrative markets for companies in the cartilage degeneration industry.
People are more involved in outdoor and sports activities than ever before owing to the increasing focus on health and fitness and this has resulted in a rise in sports injuries, which is expected to promulgate cartilage degeneration market potential throughout the forecast period.
“High Costs of Surgeries to Hamper Market Growth”
Bone therapies and surgeries are usually associated with a hefty price tag owing to the use of advanced therapeutics and technologies that increase overall treatment costs. This factor is expected to have a negative impact on cartilage repair/cartilage regeneration market growth across the forecast period. The absence of favorable reimbursement policies is also a prospect that could potentially slow down cartilage degeneration market potential going forward.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regions Hold a Bright Future for Cartilage Degeneration Treatment Providers?
“North America & Asia Pacific to Provide Highly Attractive Business Scope”
The cartilage degeneration market in North America accounts for a dominant market share at present and is expected to hold its position throughout the forecast period. The presence of developed healthcare infrastructure, favorable reimbursement policies, increasing obesity, rising number of sports injuries, and advancements in cartilage repair treatments are some of the prime factors that are predicted to shape cartilage degeneration market growth in this region.
The Canada cartilage degeneration market is projected to exhibit evolution at a CAGR of 4.5% over the next five years.
The Asia Pacific cartilage degeneration market is anticipated to witness expansion at a higher CAGR than other regions owing to the increasing geriatric population and rising availability of cartilage degeneration treatments. Increasing investments in healthcare infrastructure development, supportive government initiatives, growing geriatric population, and increasing adoption of advanced treatment technologies are other factors that could dictate cartilage degeneration market growth through 2027.
China, India, and Japan are projected to be the key markets in this region across the forecast period. The China cartilage degeneration market is slated to evolve at a 5% CAGR throughout the forecast period to end up with a revenue valuation of US$ 2.8 billion by the end of 2027.
Meanwhile, the market for cartilage degeneration in Japan is anticipated to progress at a CAGR of 4.8% over the coming years. The Europe cartilage degeneration market is also anticipated to be a rewarding market owing to the rising incidence of osteoarthritis and increasing investments in research and development of novel cartilage repair therapeutics.
Fact.MR, a market research and competitive intelligence provider, has created a detailed assessment of opportunities in the cartilage degeneration market in all the major and minor regions in this revised cartilage degeneration market survey.
Country-wise Insights
How Opportune is the U.S. Cartilage Degeneration Market?
“High Prevalence of Obesity Driving Sales of Cartilage Repair & Regeneration Products”
The United States has witnessed a substantial rise in its obese population in recent years and this trend is expected to be prevalent across the forecast period as well. Increasing obesity puts people more at risk of joint pain and joint degeneration resulting in heightened cartilage degeneration. The increasing senescent population in this region is also predicted to favor cartilage degeneration market potential as they are more prone to be affected by bone degeneration.
The increasing availability of cartilage degeneration treatment products and procedures, the presence of developed healthcare infrastructure, and favorable reimbursement policies are other factors that uplift cartilage degeneration market potential through 2027.
The United States cartilage degeneration market in 2022 is valued at US$ 3.4 billion.
Category-wise Insights
Which Procedure is Expected to Lead Overall Market Growth?
“Cartilage Degeneration Market Revenue Led by Rising Joint Replacement Procedures”
The global cartilage degeneration market, based on product, is segmented into joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, autologous chondrocyte implantation, and others.
Joint replacement procedures account for a lion’s share in the global cartilage degeneration marketplace and are anticipated to maintain this dominant stance across the forecast period owing to the rising number of joint replacement surgeries being performed across the world. High success rates of joint replacement procedures are primarily driving their popularity and are expected to do so through 2027.
- As per statistics provided by the American Academy of Orthopedic Surgeons (AAOS), 90% of the people who have undergone knee replacement surgery witnessed a significant reduction in pain and improvement in physical functioning.
Demand for joint replacement procedures is anticipated to rise at a CAGR of around 6% over the next five years and account for an estimated revenue of US$ 5.7 billion by 2027-end.
What is the Demand Outlook for Knee Cartilage Repair?
“Increasing Number of Knee Surgeries Driving Need for Knee Cartilage Repair”
The global cartilage degeneration market, based on application, is segmented into knees, hips, and others.
Knee injuries have risen in incidence over the past few years and are the most common type of trauma prevagrowing geriatric populationlent in the global marketplace. Advancements in knee replacement surgeries and favorable reimbursement for knee replacement surgeries are also expected to favor knee cartilage repair market growth over the coming years.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Top companies in the cartilage degeneration industry are focusing on creating novel cartilage repair and restoration products to increase their business potential.
- Cytonics, a biotechnology research and development company specializing in therapeutics for osteoarthritis is focusing on creating a blood protein that blocks destructive enzymes that cause degeneration of cartilage tissue. The CYT-108 is an advanced genetically engineered variant of Alpha -2-macroglobulin, a blood protein that helps in cartilage repair by blocking out destructive enzymes.
Companies in the cartilage degeneration market are also focusing on obtaining new approvals for their products to enhance their market presence and drive revenue generation capacity.
- In March 2022, CartiHeal Ltd., an Israel-based developer of implants for the treatment of cartilage defects announced that its Agili-C™ implant was granted Premarket Approval (PMA) by the U.S. FDA (Food and Drug Administration). The approval was based on the results of a two-year IDE clinical study.
Key Segments in Cartilage Degeneration Industry Research
-
By Procedure :
- Joint Replacements
- Chondroplasty
- Osteochondral Transplants
- Microfracture
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Autologous Chondrocyte Implantation
- Others
-
By Application :
- Knees
- Hips
- Others
-
By Treatment Delivery Channel :
- Hospitals
- Academic & Research Institutes
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Global Cartilage Degeneration Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Cartilage Degeneration Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Cartilage Degeneration 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Cartilage Degeneration Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Source Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Cartilage Degeneration – Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Cartilage Degeneration 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Cartilage Degeneration Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2027 5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027, By Procedure 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Procedure, 2017-2021 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Procedure, 2022-2027 6.3.1. Joint Replacements 6.3.2. Chondroplasty 6.3.3. Osteochondral Transplants 6.3.4. Microfracture 6.3.5. Meniscus Transplants 6.3.6. Cell-based Cartilage Resurfacing 6.3.7. Autologous Chondrocyte Implantation 6.3.8. Others 6.4. Market Attractiveness Analysis By Procedure 7. Global Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027, by Application 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Application , 2017-2021 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2027 7.3.1. Knees 7.3.2. Hips 7.3.3. Others 7.4. Market Attractiveness Analysis By Application 8. Global Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027, by Treatment Delivery Channel 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Treatment Delivery Channel, 2017-2021 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment Delivery Channel, 2022-2027 8.3.1. Hospitals 8.3.2. Academic & Research Institutes 8.3.3. Specialty Clinics 8.3.4. Ambulatory Surgical Centers 8.3.5. Others 8.4. Market Attractiveness Analysis By Treatment Delivery Channel 9. Global Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2027 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Procedure 10.3.3. By Application 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Procedure 10.4.3. By Application 11. Latin America Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Procedure 11.3.3. By Application 11.3.4. By Treatment Delivery Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Procedure 11.4.3. By Application 11.4.4. By Treatment Delivery Channel 12. Europe Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Procedure 12.3.3. By Application 12.3.4. By Treatment Delivery Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Procedure 12.4.3. By Application 12.4.4. By Treatment Delivery Channel 13. East Asia Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Procedure 13.3.3. By Application 13.3.4. By Treatment Delivery Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Procedure 13.4.3. By Application 13.4.4. By Treatment Delivery Channel 14. South Asia & Oceania Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Procedure 14.3.3. By Application 14.3.4. By Treatment Delivery Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Procedure 14.4.3. By Application 14.4.4. By Treatment Delivery Channel 15. Middle East and Africa Cartilage Degeneration Market Analysis 2017-2021 and Forecast 2022-2027 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2027 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Procedure 15.3.3. By Application 15.3.4. By Treatment Delivery Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Procedure 15.4.3. By Application 15.4.4. By Treatment Delivery Channel 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. DePuy Synthes 17.3.1.1. Company Overview 17.3.1.2. Source overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Zimmer Biomet 17.3.2.1. Company Overview 17.3.2.2. Source overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Stryker Corporation 17.3.3.1. Company Overview 17.3.3.2. Source overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Smith & Nephew plc 17.3.4.1. Company Overview 17.3.4.2. Source overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. B. Braun Melsungen AG 17.3.5.1. Company Overview 17.3.5.2. Source overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Medtronic plc. 17.3.6.1. Company Overview 17.3.6.2. Source overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Johnson & Johnson (DePuy Synthes) 17.3.7.1. Company Overview 17.3.7.2. Source overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Osiris Therapeutics Inc. 17.3.8.1. Company Overview 17.3.8.2. Source overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Vericel Corporation 17.3.9.1. Company Overview 17.3.9.2. Source overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Anika Therapeutics Inc. 17.3.10.1. Company Overview 17.3.10.2. Source overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 17.3.11. MEDIPOST Co. Ltd. 17.3.11.1. Company Overview 17.3.11.2. Source overview 17.3.11.3. SWOT Analysis 17.3.11.4. Key Developments 17.3.12. CONMED Corporation 17.3.12.1. Company Overview 17.3.12.2. Source overview 17.3.12.3. SWOT Analysis 17.3.12.4. Key Developments 17.3.13. Arthrex Inc. 17.3.13.1. Company Overview 17.3.13.2. Source overview 17.3.13.3. SWOT Analysis 17.3.13.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 02: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 3: Global Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 04: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 05: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 06: Global Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 07: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 80: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 09: Global Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 10: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Region, 2017-2021
Table 11: Global Cartilage Degeneration Market Value (US$ Mn) Analysis, by Region, 2022-2027
Table 12: Global Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2027
Table 13: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 14: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 15: North America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 16: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 17: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 18: North America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 19: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 20: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 21: North America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 22: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 23: North America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 24: North America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 25: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 26: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 27: Latin America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 28: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 29: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 30: Latin America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 31: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 32: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 33: Latin America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 34: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 35: Latin America Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 36: Latin America Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 37: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 38: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 39: Europe Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 40: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 41: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 42: Europe Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 43: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 44: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 45: Europe Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 46: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 47: Europe Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 48: Europe Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 49: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 50: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 51: East Asia Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 52: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 53: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 54: East Asia Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 55: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 56: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 57: East Asia Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 58: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 59: East Asia Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 60: East Asia Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 61: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 62: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 63: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 64: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 65: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 66: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 67: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 68: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 69: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 70: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 71: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 72: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
Table 73: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 74: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Country, 2022-2027
Table 75: MEA Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2027
Table 76: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2017-2021
Table 77: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Procedure, 2022-2027
Table 78: MEA Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022-2027
Table 79: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 80: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Application, 2022-2027
Table 81: MEA Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2027
Table 82: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017-2021
Table 83: MEA Cartilage Degeneration Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022-2027
Table 84: MEA Cartilage Degeneration Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022-2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 02: Global Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 03: Global Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 04: Global Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 05: Global Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 06: Global Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 07: Global Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 08: Global Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 09: Global Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 10: Global Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 11: Global Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 12: Global Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 13: Global Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 14: Global Cartilage Degeneration Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Cartilage Degeneration Market Y-o-Y Growth Projections by Region, 2022-2027
Figure 16: Global Cartilage Degeneration Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 18: North America Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 19: North America Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2022-2027
Figure 20: North America Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 21: North America Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 23: North America Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 24: North America Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 25: North America Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 26: North America Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 27: North America Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 28: North America Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 29: North America Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 30: North America Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 31: North America Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 32: North America Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 33: Latin America Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 34: Latin America Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 35: Latin America Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 36: Latin America Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 37: Latin America Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 39: Latin America Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 40: Latin America Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 41: Latin America Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 42: Latin America Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 43: Latin America Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 44: Latin America Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 45: Latin America Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 46: Latin America Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 47: Latin America Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 48: Latin America Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 49: Europe Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 50: Europe Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 51: Europe Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 52: Europe Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 53: Europe Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 55: Europe Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 56: Europe Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 57: Europe Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 58: Europe Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 59: Europe Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 60: Europe Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 61: Europe Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 62: Europe Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 63: Europe Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 64: Europe Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 65: East Asia Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 66: East Asia Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 67: East Asia Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 68: East Asia Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 69: East Asia Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 71: East Asia Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 72: East Asia Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 73: East Asia Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 74: East Asia Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 75: East Asia Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 76: East Asia Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 77: East Asia Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 78: East Asia Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 79: East Asia Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 80: East Asia Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 81: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 82: South Asia & Oceania Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 83: South Asia & Oceania Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 84: South Asia & Oceania Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 85: South Asia & Oceania Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 87: South Asia & Oceania Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 88: South Asia & Oceania Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 89: South Asia & Oceania Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 90: South Asia & Oceania Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 91: South Asia & Oceania Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 92: South Asia & Oceania Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 93: South Asia & Oceania Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 94: South Asia & Oceania Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 95: South Asia & Oceania Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 96: South Asia & Oceania Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Figure 97: MEA Cartilage Degeneration Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 98: MEA Cartilage Degeneration Market Value (US$ Mn) Forecast and Analysis, 2022-2027
Figure 99: MEA Cartilage Degeneration Market Value Y-o-Y Growth and Forecast, 2017-2027
Figure 100: MEA Cartilage Degeneration Market Incremental $ Opportunity, 2022-2027
Figure 101: MEA Cartilage Degeneration Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Cartilage Degeneration Market Y-o-Y Growth Projection by Country, 2022-2027
Figure 103: MEA Cartilage Degeneration Market Attractiveness Analysis by Country, 2022-2027
Figure 104: MEA Cartilage Degeneration Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 105: MEA Cartilage Degeneration Market Y-o-Y Growth Projections by Procedure, 2022-2027
Figure 106: MEA Cartilage Degeneration Market Attractiveness Analysis by Procedure, 2022-2027
Figure 107: MEA Cartilage Degeneration Market Share and BPS Analysis by Application, 2022 & 2027
Figure 108: MEA Cartilage Degeneration Market Y-o-Y Growth Projections by Application, 2022-2027
Figure 109: MEA Cartilage Degeneration Market Attractiveness Analysis by Application, 2022-2027
Figure 110: MEA Cartilage Degeneration Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 111: MEA Cartilage Degeneration Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022-2027
Figure 112: MEA Cartilage Degeneration Market Attractiveness Analysis by Treatment Delivery Channel, 2022-2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the outlook for joint replacements as per this Fact.MR report?
Joint replacement procedures are anticipated to account for US$ 5.7 billion by the end of 2027.
What is the estimated valuation of the cartilage degeneration market for 2027?
By 2027, the global market for cartilage degeneration is slated to reach US$ 16 billion.
What is the growth rate of the cartilage degeneration market?
The global cartilage degeneration market is predicted to steadily evolve at 5.7% CAGR through 2027.
How does this Fact.MR research characterize the market in China?
The market in China is predicted to expand at 6% CAGR and account for a value of US$ 2.8 billion by 2027.
What is the current revenue of the cartilage degeneration market?
Currently, the global cartilage degeneration market stands at US$ 12.1 billion.
Which is the leading regional market for cartilage degeneration?
North America leads the global market and accounts for a valuation of US$ 3.4 billion in 2022.
Who are the major companies operating in the cartilage degeneration market?
Medtronic plc., Johnson & Johnson (DePuy Synthes), Osiris Therapeutics Inc., Vericel Corporation, Anika Therapeutics Inc., MEDIPOST Co. Ltd., CONMED Corporation, and Arthrex Inc. are major companies dealing in cartilage degeneration treatment products.
Cartilage Degeneration Market